Hepatitis E virus infections in patients with MS on oral disease-modifying treatment

OBJECTIVE: To test whether patients with MS on disease-modifying treatments (DMTs) are at a higher risk of acute or chronic hepatitis E virus (HEV) infections or extrahepatic manifestations, we monitored approximately 1,100 persons with MS (pwMS) during 3 years for HEV infection. METHODS: This is an...

Descripción completa

Detalles Bibliográficos
Autores principales: Diebold, Martin, Fischer-Barnicol, Bettina, Tsagkas, Charidimos, Kuhle, Jens, Kappos, Ludwig, Derfuss, Tobias, Décard, Bernhard F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6705628/
https://www.ncbi.nlm.nih.gov/pubmed/31454772
http://dx.doi.org/10.1212/NXI.0000000000000594

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6705628/
https://www.ncbi.nlm.nih.gov/pubmed/31454772
http://dx.doi.org/10.1212/NXI.0000000000000594

Ejemplares similares